We are live on ! Find out more
IDNA icon

iShares Genomics Immunology and Healthcare ETF
IDNA

58 hedge funds and large institutions have $55M invested in iShares Genomics Immunology and Healthcare ETF in 2025 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 8

21% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 14

14% more funds holding

Funds holding: 51 → 58 (+7)

12% more capital invested

Capital invested by funds: $49.1M → $55M (+$5.9M)

0.35% more ownership

Funds ownership: 41.36% → 41.71% (+0.35%)

Holders
58
Holders Change
+7
Holders Change %
+13.73%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
17
Reduced
14
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$1.51M
2
Ameriprise
Ameriprise
Minnesota
+$741K
3
LPL Financial
LPL Financial
California
+$352K
4
FTUS
Flow Traders U.S.
New York
+$352K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$326K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$1.9M
2
USCWA
U.S. Capital Wealth Advisors
Texas
-$553K
3
Citadel Advisors
Citadel Advisors
Florida
-$328K
4
WBG
Wharton Business Group
Pennsylvania
-$325K
5
SWGC
Summit Wealth Group (Colorado)
Colorado
-$292K
Name Holding Trade Value Shares
Change 		Change in
Stake
HWA
51
HHM Wealth Advisors
Tennessee
$3.54K – – –
PNC Financial Services Group
52
PNC Financial Services Group
Pennsylvania
$2.62K – – –
1NWS
53
1 North Wealth Services
Maryland
$2.23K – – –
GSWM
54
Golden State Wealth Management
California
$2.06K – – –
RF
55
Rossby Financial
Florida
$1.47K -$206 -8 -13%
BBPWM
56
Blue Bell Private Wealth Management
Pennsylvania
$1.44K – – –
AF
57
Allworth Financial
California
$1.05K +$1.03K +40 New
AC
58
AlphaCore Capital
California
$20 +$26 +1 New
USCWA
59
U.S. Capital Wealth Advisors
Texas
– -$553K -23,427 Closed
M
60
MATAURO
New York
– -$261K -11,067 Closed
SWGC
61
Summit Wealth Group (Colorado)
Colorado
– -$292K -1,747 Closed
Bank of Montreal
62
Bank of Montreal
Ontario, Canada
– -$18.4K -780 Closed
AAP
63
Arax Advisory Partners
Colorado
– -$4.84K -205 Closed
PS
64
Principal Securities
Iowa
– -$4.34K -184 Closed
AWM
65
AE Wealth Management
Kansas
– -$3.5K -148 Closed
WANY
66
Wealthspire Advisors (New York)
New York
– -$534 -23 Closed
1 2
3

IDNA Hedge Fund Activity: Q4 2025 in Review

58 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q4 2025, worth a combined $55M — up 12% from $49.1M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new IDNA positions and 8 closed out — a net gain of 7 holders — while 17 added to existing stakes and 14 trimmed.

The largest buyer was Bank of America, adding an estimated $1.51M. The largest seller was UBS Group, cutting an estimated $1.9M.

  • 58 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q4 2025, up from 51 in Q3 2025.
  • Funds reported $55M of iShares Genomics Immunology and Healthcare ETF stock for Q4 2025, up 12% quarter-over-quarter.
  • 15 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q4 2025 and 8 closed out, a net change of +7 holders.
  • The largest iShares Genomics Immunology and Healthcare ETF buyer in Q4 2025 was Bank of America, an estimated $1.51M added.
  • The largest iShares Genomics Immunology and Healthcare ETF seller in Q4 2025 was UBS Group, an estimated $1.9M sold.

Based on aggregated 13F filings for Q4 2025.